European Foundation For The Study Of Chronic Liver Failure

3 trials 2 recruiting Academic / non-commercial

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

2 Recruiting

0 Completed trials

9 Countries active

3 Unique IMPs

N/A Results reported

Phase III

Phase II

Phase III: 2 Phase II: 1

Top IMPs

HUMAN SERUM ALBUMIN 3 SODIUM CHLORIDE 2 ENOXAPARIN SODIUM 1

All trials

3 total

An European multinational study of a personalized approach of human albumin administration in patients with cirrhosis of the liver and compl… Not authorised

2022-501006-34-00 Phase III 6 countries HUMAN SERUM ALBUMIN; SODIUM CHLORIDE
A novel COMBinATorial therapy with albumin and enoxaparin in patients with decompensated cirrhosis at high-risk of poor outcome (COMBAT tria… Recruiting

2023-507073-18-00 Phase II 4 countries ENOXAPARIN SODIUM; HUMAN SERUM ALBUMIN
An European multinational study of a personalized approach of human albumin administration in patients with cirrhosis of the liver and compl… Recruiting

2022-501006-34-01 Phase III 7 countries HUMAN SERUM ALBUMIN; SODIUM CHLORIDE

Showing 1–3 of 3 trials

← All sponsors A–Z